Navigation Links
Neuralstem CEO to Speak on ALS Panel at World Stem Cell Summit
Date:9/8/2008

ROCKVILLE, Md., Sept. 8 /PRNewswire-FirstCall/ -- Neuralstem Inc., CEO, Richard Garr, will be a featured panelist discussing stem cells and ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease) at the 2008 World Stem Cell Summit in Madison, Wisconsin, on September 22, at 2:00 CDT. In a presentation prior to the panel, Mr. Garr will talk about Neuralstem's plans for an ALS trial and give an update of the Company's filing status with the FDA.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO )

The World Stem Cell Summit (http://www.worldstemcellsummit.com) is sponsored by the Genetics Policy Institute, the University of Wisconsin- Madison Stem Cell & Regenerative Medicine Center and WiCell Research Institute, Inc.

About Neuralstem

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia.

Major Central Nervous System diseases targeted by the Company with research programs currently underway include: Ischemic Spastic Paraplegia, Traumatic Spinal Cord Injury and ALS. The company's cells have extended the life of rats with ALS (Lou Gehrig's disease) as reported the journal TRANSPLANTATION, in collaboration with Johns Hopkins University researchers, and also reversed paralysis in rats with Ischemic Spastic Paraplegia, as reported in NEUROSCIENCE on June 29, 2007, in collaboration with researchers at University of California San Diego. The Company expects to file its first IND (Investigational New Drug) application with the FDA for ALS in the fall.

Cautionary Statement Regarding Forward Looking Information

This news release may
'/>"/>

SOURCE Neuralstem Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Neuralstem Shares Accepted for Trading on Amex(R)
2. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
3. Patent Office Rules in Neuralstems Favor in Dispute with StemCells, Inc.
4. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
5. Neuralstem Sues StemCells, Inc. Over New Patent
6. Neuralstem Responds to New StemCells, Inc. Lawsuit
7. Neuralstem Fills Key Product Development Position
8. Neuralstem Reports Second Quarter Financial Results and Highlights
9. AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium
10. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
11. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... DuPont Tate & Lyle Bio ... it has appointed Skidmore Sales & Distributing ... Essex Grain Products and Processor’s ... in the food and beverage markets. The ... mid-western states: Alabama, Arkansas, Connecticut, Delaware, Florida, ...
(Date:9/11/2014)... LONDON , Sept. 11, 2014 ... (CRT), the charity,s development and commercialisation arm, have reached ... biotechnology company in the emerging field of regenerative ... AST-VAC2 into clinical trials in subjects with non-small ... tenth treatment to enter Cancer Research UK,s Clinical ...
(Date:9/11/2014)... The Stem Cell Institute, located in ... umbilical cord stem cell therapy on Saturday, September 20, 2014 ... Resort from 1:00 pm to 4:00 pm. , Stem ... – “Umbilical Cord Stem Cell Clinical Trials for MS and ... founder of the Stem Cell Institute and Medistem Panama Inc. ...
(Date:9/10/2014)... Brunswick, New Jersey (PRWEB) September 11, 2014 ... will host its annual Innovations in Dermatological Sciences ... meeting will focus on how the university, industry ... dermatological research into clinical use. , This conference ... had experience with cross-sector collaboration, to share their ...
Breaking Biology Technology:DuPont Tate & Lyle Bio Products Appoints Skidmore Sales as Distributor for Zemea® USP 2DuPont Tate & Lyle Bio Products Appoints Skidmore Sales as Distributor for Zemea® USP 3Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 2Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 3Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 4Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 5Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 6Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 7Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 8Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014 2Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014 3Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014 4Innovations in Dermatological Sciences 2014 2Innovations in Dermatological Sciences 2014 3
... N.J., March 26 Vicus Therapeutics, LLC, ... Rao, Vice President Clinical Research and Development, ... 15th International,Molecular Medicine Tri-Conference on March 28st ... Convention Center in San Francisco. Dr. Rao ...
... JOLLA, Calif., March 26 TorreyPines,Therapeutics, Inc. (Nasdaq: ... and year ended December 31, 2007. For the full ... a net loss of $23.4 million.,Cash and cash equivalents ... made meaningful progress in our three clinical development programs,in ...
... 26 Pharsight,Corporation (Nasdaq: PHST ), a leading ... clinical drug,development announced today that it will be presenting ... Conference on April 2, 2008 at the Palms Las,Vegas. ... Vice President and CFO, will be presenting on April ...
Cached Biology Technology:TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 2TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 3TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 4TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 5TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 6TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 7Pharsight to Present at B. Riley & Co. 9th Annual Las Vegas Investor Conference 2
(Date:9/11/2014)... DDT, American peregrine falcons ( Falco peregrines anatum ) ... stop rearing young birds in captivity and placing them ... models that year in ESA,s journal Ecological ... in California, with and without direct human intervention in ... would continue to recover without captive rearing, though the ...
(Date:9/11/2014)... 2014)Scientists today unveiled what appears to be the first ... New fossils of the massive Cretaceous-era predator reveal it ... years ago, providing the most compelling evidence to date ... an aquatic environment. The fossils also indicate that ... roam the Earth, measuring more than 9 feet longer ...
(Date:9/11/2014)... ago, a sudden, catastrophic event plunged much of the ... drought. This drastic climate changethe Younger Dryascoincided with the ... and the mastodon, and resulted in major declines in ... culture. , With limited evidence, several rival theories have ... such as a collapse of the North American ice ...
Breaking Biology News(10 mins):Volunteer 'eyes on the skies' track peregrine falcon recovery in California 2Volunteer 'eyes on the skies' track peregrine falcon recovery in California 3Volunteer 'eyes on the skies' track peregrine falcon recovery in California 4Volunteer 'eyes on the skies' track peregrine falcon recovery in California 5Scientists report first semiaquatic dinosaur, Spinosaurus 2Scientists report first semiaquatic dinosaur, Spinosaurus 3Scientists report first semiaquatic dinosaur, Spinosaurus 4Microscopic diamonds suggest cosmic impact responsible for major period of climate change 2
... A large collaborative study has added to the ... a person will be. The research, published by Cell ... of Human Genetics , identifies uncommon and previously unknown ... the genetic architecture of other complex traits. Although ...
... Most agricultural crops require large quantities of ... for growers is finding ways to balance the ... potentially harmful nitrates that can leach into ground ... "low-input" approaches is challenging researchers to identify genotypes ...
... traditionally relied heavily on hand thinning, a necessary but ... costs and a limited workforce, peach and other stone ... string thinners to minimize the need for hand thinning. ... when it was evaluated in four U.S. growing regions; ...
Cached Biology News:Large-scale analysis identifies new genetic alterations associated with height 2Improving nitrogen use efficiency lessens environmental impact 2Hybrid string blossom thinner tested in peach orchards 2
Goat anti-VAV2 Class: Antibody Product Group: Miscellaneous Antibody...
Indoleamine 2,3-dioxygenase [IDO]...
Request Info...
Pancreatic Cell Cryopreservation Medium (2X) is intended for the cryopreservation of LT2 Immortalized Pancreatic Mesenchymal Cells (SCR013) and VIT1 Primary Pancreatic Mesenchymal Cells (SCR014)....
Biology Products: